U.S. Military Base AFFF PFAS Contamination: Cancer Risk, Exposure Pathways, and the Lawsuits Holding Chemical Companies Accountable
You are reading this because someone in your family has cancer, and you lived near a military base. Or you served as a firefighter and you held the nozzle on the foam yourself. Or you drank the water in a town like Fairborn, Ohio, or Falmouth, Massachusetts, and nobody told you what was in it. The question sitting on your chest at 2 a.m. is the one every person in your position eventually asks: was this caused by something they knew about and didn’t tell me?
We are going to answer that question the way a senior trial team answers it — with the science, the law, the evidence, and the honest truth about what a case like this is worth and what it costs to bring one. We are Attorney911 — The Manginello Law Firm, PLLC. We handle toxic tort cases and the catastrophic injuries and wrongful deaths that follow them. What we give you here is the same analysis we would give you across a kitchen table if you called us tonight. The difference is that here, you can read it without anyone on the other end of a phone call pressuring you.
Here is the first thing you need to hear: what happened to you is not a mystery. It is a pattern. More than 700 U.S. Department of Defense installations have or are likely to have elevated levels of per- and polyfluoroalkyl substances — PFAS — in their water or soil, largely from decades of using a product called AFFF, aqueous film-forming foam, to train firefighters and put out jet fuel fires. The DOD needs to remove more than 2 million gallons of AFFF concentrate plus another 1.5 million gallons of rinsate from its facilities. And researchers from Harvard have found that without remediation, the elevated exposure near more than 300 military facilities could persist for centuries. Not years. Centuries.
The Scale of the Contamination: 700 Military Bases, Millions of Gallons, and a Problem That Outlives Everyone It Hurt
The number that tells you this is not a local problem is 700. The DOD’s own PFAS progress report tracks assessment at 723 installations. Every one of those bases used AFFF — sprayed it, poured it, trained with it, washed it into the ground — for decades. The foam seeped into soil. It reached groundwater. It traveled. And it does not break down.
PFAS are called “forever chemicals” for a reason that is not marketing. The carbon-fluorine bond that gives these molecules their heat-resistant, oil-repellent properties is one of the strongest bonds in organic chemistry. The human body cannot metabolize them. The environment cannot degrade them. They accumulate — in soil, in water, in blood, in organs — and they stay. The biological half-lives of some PFAS compounds in the human body are measured in years. In the environment, they are effectively permanent.
The DOD’s own numbers tell the scale of what was discharged. More than 2 million gallons of AFFF concentrate sit at military facilities awaiting disposal. Another 1.5 million gallons of rinsate — the contaminated washwater from cleaning fire trucks and airplane hangars — must also be removed before installations can transition to the fluorine-free alternative the military is now adopting, called F3. Millions more gallons need cleanup at civilian airports, municipal fire training sites, and other non-military facilities.
At Wright-Patterson Air Force Base near Fairborn, Ohio, the base completed AFFF removal and transitioned to F3 in July 2024 — ahead of the October 1, 2026 congressional deadline. But as of 2024, three of twenty-two private drinking water wells near the facility still showed PFOA and PFOS levels exceeding federal maximum contaminant levels. The foam is gone from the base. The contamination remains in the community.
At Joint Base Cape Cod, the situation is worse and getting worse. The water table sits less than ten feet below the surface, meaning contaminants reach groundwater almost immediately. Groundwater contamination is actively spreading toward the communities of Falmouth and Mashpee. Harvard researchers found that the majority of what exists in AFFF-contaminated soil is not yet PFAS — it is PFAS precursors, chemical compounds that bacteria in the soil convert into PFAS over time.
“The majority of what you find in AFFF is the precursor. There was a lot of AFFF used, so there are a ton of precursors in the soil at the fire training areas. . . . This is going to go on for a very long time.”
That is Elsie Sunderland, an environmental chemistry researcher at Harvard, speaking about Joint Base Cape Cod and other military facilities where AFFF was used. Her team’s 2023 study, published in Environmental Science & Technology, found that PFAS precursors are abundant at military fire training areas — and that when nitrate-oxidizing bacteria interact with those precursors, they convert them into PFAS compounds, typically PFBS and PFHxS, which then trickle into the groundwater. What you see in the water around these bases is, in her words, “such a tiny fraction of the overall burden.” The rest is still in the soil, still converting, still coming.
And the cleanup is not keeping pace. A mid-2026 investigation found that the DOD has delayed PFAS cleanup timelines at 178 sites, pushing remediation back between one and twenty years. The DOD’s PFAS progress report — the public’s primary tool for tracking what is happening at each installation — was last updated in September 2025. When asked whether AFFF removal has been completed at any U.S. military sites, a DOD spokesman would only say the department “continues to remove AFFF from its installations” and plans to update its PFAS website with site-specific information “in the future.”
What AFFF Is and How PFAS Contamination Spreads From Military Bases Into Surrounding Communities
AFFF was designed to do one thing supremely well: extinguish jet fuel fires. It works by forming a film on top of burning fuel that smothers the flames and prevents re-ignition. The military has used it since the 1960s — for real emergencies, yes, but far more often for training. Firefighters would spray AFFF onto controlled fuel fires, again and again, at dedicated fire training areas on base. The foam soaked into the ground. It ran into drains. It washed into retention ponds. And every time it rained, it moved a little farther.
Here is the exposure pathway, step by step. AFFF concentrate contains PFAS — historically, PFOA and PFOS, and a range of precursor compounds. When AFFF is discharged at a fire training area, the PFAS infiltrates soil. From there, three things happen simultaneously. First, PFAS binds to soil particles but also dissolves in water, so rainfall carries it downward. Second, when it reaches the water table — which at some installations, like Joint Base Cape Cod, is fewer than ten feet below the surface — it enters the groundwater system and begins to migrate. Third, PFAS precursors in the soil are converted by naturally occurring bacteria into terminal PFAS compounds over years and decades, creating a continuous source of new contamination even after AFFF use has stopped.
The groundwater then feeds private drinking water wells and municipal water supplies. The DOD’s own data from Wright-Patterson shows that even after AFFF removal is complete at the base, three of twenty-two nearby private wells still exceed federal safety limits. At Joint Base Cape Cod, contamination is spreading toward Falmouth and Mashpee. This is not historical contamination that has been cleaned up. This is active, ongoing contamination that is getting worse in places where soil remediation has not occurred.
For military firefighters and base personnel, the exposure pathway is more direct. They handled AFFF concentrate. They sprayed it. They cleaned equipment that had been filled with it. They breathed aerosolized foam during training exercises. They wore it on their skin. Occupational exposure to AFFF concentrate produces PFAS blood serum levels far higher than environmental exposure through drinking water — and the firefighters who used the product most heavily are the people whose bodies carry the highest doses.
For surrounding communities, the pathway is the water. You drank it. You cooked with it. You bathed your children in it. You may have been doing so for years or decades without knowing that the water coming out of your tap had traveled through soil contaminated by a product the military was spraying half a mile away.
The Diseases Linked to PFAS Exposure From AFFF Foam
The science connecting PFAS to human disease is not speculative. The C8 Science Panel — an independent group of epidemiologists established as part of a legal settlement between DuPont and residents of the Mid-Ohio Valley — conducted one of the most thorough PFAS health studies ever undertaken. In 2012, the panel found a “probable link” between PFOA and six conditions: kidney cancer, testicular cancer, high cholesterol, thyroid disease, pregnancy-induced hypertension, and ulcerative colitis.
The world’s leading cancer authority has weighed in. The International Agency for Research on Cancer classified PFOA as Group 1 — carcinogenic to humans — and PFOS as Group 2B — possibly carcinogenic to humans. The EPA set the health-based goal for PFOA and PFOS in drinking water at zero, meaning the agency found no amount it considers safe. The enforceable maximum contaminant level is 4.0 parts per trillion — roughly a single drop spread across twenty Olympic swimming pools.
Here is what that means for the person reading this page. If you lived near a military base where AFFF was used and you have been diagnosed with kidney cancer or testicular cancer, the disease you are fighting has been scientifically linked to the chemical that was in the water you drank. If you have thyroid disease, ulcerative colitis, or pregnancy-induced hypertension and you have documented exposure to PFAS-contaminated water, the same body of science connects your condition to that exposure.
The mechanism is biologically specific. PFAS are persistent, bioaccumulative chemicals that bind to serum proteins in the blood. They concentrate in the liver and the kidneys. They are not metabolized — the body cannot break them down and excrete them. They interfere with endocrine function, they disrupt immune response, and they promote oxidative stress and inflammation. For kidney cancer, the proposed pathway involves chronic renal concentration of PFAS and genotoxic damage to renal cells. For testicular cancer, the pathway involves endocrine disruption affecting testicular development and cellular regulation.
The defense will exploit two features of this science. First, PFAS is ubiquitous — nearly everyone in the United States has some level of PFAS in their blood. The defense will argue that you cannot prove their product caused your cancer when the entire population carries these chemicals. Second, kidney cancer and testicular cancer have other known risk factors, and the defense will argue your cancer came from something else.
Both arguments have answers. The ubiquity defense collapses when you can show elevated exposure — a contaminated water district, an occupational source like firefighting, residence proximity to a known AFFF discharge site — combined with blood serum testing that documents PFAS levels significantly higher than background. The C8 Science Panel’s dose-response findings showed that risk increases with dose. You do not have to prove PFAS is the only cause. You have to prove it was a substantial contributing factor. And for someone who drank contaminated water for twenty years and has blood serum levels five or ten times the national average, that proof is built into the numbers.
Who Is Responsible: The Chemical Manufacturers and the Department of Defense
There are two categories of defendant in AFFF PFAS cases, and each requires a different legal approach.
The primary defendants are the AFFF chemical manufacturers — the companies that designed, manufactured, marketed, and sold PFAS-based firefighting foam. These are public-record defendants in the consolidated multidistrict litigation pending in federal court in South Carolina. They include 3M Company, Tyco Fire Products, Chemours, DuPont, and others. The claims against them are products liability claims — strict liability for a defective design, failure to warn of known health risks, and negligence in continuing to produce and market a dangerous product when safer alternatives existed.
The corporate structure of these defendants is where cases get won or lost. The Chemours Company is a 2015 spinoff from DuPont that holds much of the legacy PFAS liability. That spinoff is itself the corporate maneuver — DuPont separated its PFAS obligations into a new company, which plaintiffs argue was designed to limit DuPont’s own exposure. DuPont de Nemours and Corteva are products of the DowDuPont split, with liability allocated among them by agreement. 3M, which announced it would exit PFAS manufacturing by the end of 2025, has already entered into publicly announced multi-billion dollar settlement frameworks with U.S. public water systems — approximately $10.3 billion in present value, paid over thirteen years. DuPont, Chemours, and Corteva agreed to approximately $1.185 billion with public water providers.
Those settlements are critical context, but they are not your settlement. The water provider settlements resolve municipal contamination claims. They contain no admission of liability. They do not compensate individuals who developed cancer after drinking contaminated water. Your personal injury case is a separate track — and it is still being fought.
The second category of defendant is the U.S. Department of Defense. The DOD used AFFF at 700-plus installations for decades, creating the contamination that exposed you. But suing the federal government requires navigating the Federal Tort Claims Act, which imposes unique barriers. The FTCA allows you to sue the United States for the negligence of federal employees — but only under circumstances where a private person would be liable under the law of the state where the act occurred. Before you can file suit, you must present a written administrative claim — a Standard Form 95 — to the appropriate federal agency, stating a specific dollar amount. You have two years from the date the claim accrues to file that administrative claim. If the agency denies it, you have six months to file suit in federal court.
The FTCA’s discretionary function exception is the biggest barrier to DOD claims. The government generally cannot be sued for policy-level judgment calls — and the DOD will argue that its decisions about how and when to use AFFF, and when to begin remediation, were policy decisions that fall within the exception’s protection. New Mexico, which has six established or suspected DOD PFAS sites, has sued the DOD to force it to stop non-emergency AFFF use and compensate affected landowners — demonstrating that the legal fight against DOD is possible but hard-fought.
For most individuals, the manufacturers are the primary path to compensation. The DOD claims are secondary and face higher procedural barriers. But the DOD’s role is critical to your case in another way: its records — usage logs, environmental assessments, sampling data, remediation timelines — are the evidence that proves your exposure pathway.
The Law That Protects You: Strict Products Liability, Failure to Warn, and the Discovery Rule
The legal framework for AFFF PFAS cases rests on several doctrines that work together. Understanding them is the difference between knowing you have a case and knowing how to win it.
Strict products liability for a defective design. Most states recognize strict products liability for defective chemical products under either the Restatement (Second) of Torts § 402A or the Restatement (Third) of Torts: Products Liability. Under strict liability, you do not have to prove the manufacturer was careless. You have to prove the product was defectively designed — that it was unreasonably dangerous when it left the manufacturer’s hands. For AFFF, the design defect theory is straightforward: the product was formulated with PFAS that are persistent, bioaccumulative, and toxic. The manufacturers could have developed fluorine-free alternatives — as the F3 foam now being adopted by the military demonstrates — but chose not to. The product was unreasonably dangerous because a safer, feasible alternative existed and was not used.
Failure to warn. The manufacturers allegedly knew or should have known of the health risks of PFAS — including cancer and reproductive harm — for decades. Internal corporate documents produced in the multidistrict litigation have already begun to surface evidence of what the manufacturers knew and when they knew it. The failure-to-warn theory holds that even if the product itself was not defectively designed, the manufacturer had a duty to warn users — military firefighters, base personnel, surrounding communities — of the known health risks, and that failure to warn caused the harm.
The discovery rule and the statute of limitations. This is the clock that scares people the most, and it is the one we need to address honestly. Toxic tort statutes of limitation typically run two to three years from the date the claim accrues. But for latent diseases like cancer that may manifest decades after the initial PFAS exposure, most states apply a discovery rule: the clock does not start ticking until you discovered, or by reasonable diligence should have discovered, both your injury and its causal connection to the toxic exposure. If you were diagnosed with kidney cancer last year and only recently learned that PFAS from AFFF at the base near your home may have caused it, your clock may have started when you made that connection — not when you were exposed twenty years ago.
Some states impose an outer deadline called a statute of repose that can cut off a claim even before discovery. The discovery rule does not defeat a repose statute. We cannot tell you on this page whether your state has a repose statute or what your specific deadline is — that depends on where you live and where your exposure occurred. What we can tell you is that the discovery rule exists in most states for latent diseases, and that assuming you are “too late” without consulting a lawyer is the most common way people lose cases they could have won.
For claims against the federal government under the FTCA, the clock is different and unforgiving. You have two years from the date the claim accrues to file an administrative claim with the appropriate federal agency. Once the agency denies your claim, you have six months to file suit in federal court. Both deadlines are jurisdictional — miss either one and the claim is “forever barred,” in the words of the statute itself.
CERCLA and the hazardous substance designation. In May 2024, the EPA designated PFOA and PFOS as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act — the Superfund law. This designation triggers federal cleanup obligations and cost-recovery mechanisms. Under CERCLA, liability is strict, joint and several, and retroactive. The manufacturers cannot defend by saying PFAS use was legal at the time — the law reaches conduct from decades ago. Any entity that released a pound or more of PFOA or PFOS in a twenty-four-hour period must report that release to the National Response Center.
Medical monitoring. For populations with documented exposure but no current disease diagnosis, medical monitoring is a separate and critical claim. Harvard research indicates that PFAS precursors in soil can continue generating contamination for centuries without remediation. People who live near contaminated installations face ongoing, elevated exposure. Medical monitoring seeks to recover the costs of regular medical surveillance — blood tests, cancer screenings, thyroid panels — designed to detect disease at earlier and more treatable stages. The case value for medical monitoring claims is lower than for cancer claims, but the right to ongoing medical surveillance is itself a meaningful recovery.
The AFFF Multidistrict Litigation in South Carolina: What It Means for Your Case
Thousands of AFFF cases are consolidated in the U.S. District Court for the District of South Carolina before Judge Richard M. Gergel. As of mid-2026, the multidistrict litigation — MDL number 2873, In re: Aqueous Film-Forming Foams Products Liability Litigation — had approximately 15,240 actions pending. That number grows every month.
An MDL is not a class action. Each plaintiff keeps an individual case. What the MDL does is centralize pretrial proceedings — discovery, motion practice, expert challenges, and bellwether trial selection — before one judge who manages the shared work. This means the corporate documents that manufacturers were forced to produce in the MDL are available to every plaintiff whose case is part of the consolidation. The internal memos, the testing data, the knowledge of health risks — all of it is shared evidence that individual cases can leverage.
The first AFFF personal-injury bellwether trial was selected to focus on kidney cancer and had been set for October 2025, but was postponed after the court identified a large backlog of unfiled cases. Bellwether trials are test cases — their results do not bind other plaintiffs, but they give both sides information about how juries respond to the evidence and what cases are worth. The bellwether schedule is moving, and anyone considering a claim should understand that the litigation is active and evolving.
The public water provider settlements — 3M’s approximately $10.3 billion present-value agreement and the DuPont/Chemours/Corteva approximately $1.185 billion agreement — are separate from the personal-injury cases. They resolve municipal contamination claims. They do not compensate individuals for cancer, thyroid disease, or other health conditions. They contain no admission of liability. But they do demonstrate that the manufacturers have acknowledged the financial magnitude of the PFAS problem, and they establish a framework for what personal-injury settlements might look like as the bellwether process unfolds.
The Regulatory Framework: EPA, CERCLA, and the Shifting Landscape of PFAS Standards
The regulatory environment for PFAS is in flux, and understanding where it stands today is essential to understanding the strength of your case.
In April 2024, the EPA finalized the first federal drinking water standards for PFAS. The maximum contaminant level for PFOA and PFOS was set at 4.0 parts per trillion each — a number so low it functions as a near-zero threshold. The health-based goal was set at zero, meaning the EPA found no amount of these chemicals in drinking water that it considers safe. Initial monitoring was required by April 2027, and MCL compliance by April 2029.
But in May 2026, the EPA proposed rescinding the drinking water limits for certain other PFAS compounds — PFHxS, PFNA, and HFPO-DA (known as GenX chemicals) — as well as the Hazard Index for mixtures of these compounds. The agency stated it would keep the PFOA and PFOS designations and drinking water regulations, but proposed extending the compliance deadline from 2029 to 2031. These changes are proposed, not final. The PFOA and PFOS limits of 4.0 ppt remain current law. But the shifting regulatory picture creates uncertainty for communities and for claims tied to compounds whose federal limits may be rescinded.
At the state level, regulation is intensifying in the absence of stable federal action. New Mexico added AFFF to its state hazardous waste list and sued the DOD to compel cleanup and compensate affected landowners. New Jersey pursued AFFF collection programs ahead of a pending sales ban. States are acting independently because the federal framework is not keeping pace with the science.
The National Defense Authorization Act mandated that the DOD phase out PFAS in AFFF by October 1, 2026, with limited exceptions for ships and research. Some bases, like Wright-Patterson, have already completed the transition to F3. But the F3 transition only stops new contamination — it does nothing about the decades of PFAS already in the soil and groundwater. And the DOD has delayed cleanup at 178 sites by one to twenty years, meaning communities near those installations face continued exposure while the remediation timeline stretches.
In February 2026, the DOD lifted a moratorium on incineration, adding it to approved disposal methods for PFAS-containing materials. EPA updated its own disposal guidance in April 2026, noting incineration’s effectiveness but warning that operating conditions must be carefully monitored. The lifting of the moratorium may accelerate disposal of the 2 million gallons of AFFF concentrate sitting at military facilities, but it does not address the contamination already in the environment — and it does not address the health consequences for people who were exposed before the cleanup even begins.
How to Know If You Were Exposed: Blood Serum Testing and Medical Monitoring
If you lived, worked, or served at or near a military base where AFFF was used, the single most important step you can take for your health and your potential case is a blood serum PFAS test.
PFAS blood testing is a clinical biomonitoring test that measures the concentration of specific PFAS compounds in your blood serum. It is not a routine blood test — you have to request it or have a physician order it. The test typically measures a panel of PFAS compounds, including PFOA, PFOS, PFHxS, PFNA, and others. The results are reported in nanograms per milliliter (ng/mL) and compared against national background levels from the CDC’s National Health and Nutrition Examination Survey.
Why does this test matter? Three reasons. First, it documents your internal dose — the actual amount of PFAS in your body, not just the amount in the water you drank. This is the biological evidence that connects your exposure to the contamination at the base. Second, it establishes a baseline for medical monitoring. If your PFAS levels are elevated, your doctor may recommend more frequent cancer screenings, thyroid panels, and other surveillance. Third, it is critical evidence for specific causation — proving that your disease is connected to PFAS exposure and not to some alternative cause.
Timing matters. The biological half-lives of PFAS compounds vary — for some, it is years. That means your blood serum levels will gradually decline after exposure stops. If you moved away from a contaminated area ten years ago, your levels may have declined significantly. The sooner you test, the more accurate the picture of your historical exposure. If you still live near a contaminated installation, your levels may still be elevated because the exposure is ongoing.
For military firefighters and base personnel who handled AFFF directly, blood serum levels are typically far higher than for community members exposed through drinking water. Occupational exposure to AFFF concentrate produces some of the highest PFAS blood levels ever recorded in humans. If you were a firefighter who trained with AFFF, your blood test is likely to show levels dramatically above national background — and that evidence is powerful.
Medical monitoring is both a health recommendation and a legal claim. If you have documented elevated PFAS exposure but no current disease diagnosis, you may be entitled to recover the costs of ongoing medical surveillance. This includes regular blood tests, cancer screenings appropriate to your exposure profile (kidney imaging for elevated PFAS, testicular exams for male firefighters), thyroid function panels, and cholesterol monitoring. The right to medical monitoring recognizes that people with documented toxic exposure face an elevated risk of disease and should not have to bear the cost of watching for it themselves.
The Evidence Clock: What Records Exist and How Fast They Disappear
Every toxic exposure case lives or dies on evidence. In AFFF PFAS cases, the evidence falls into seven categories, and each has its own clock — the period after which it can legally be destroyed, modified, or lost.
DOD PFAS progress report and site-specific assessment data. The DOD’s progress report, which tracks PFAS assessments at 723 installations, was last updated in September 2025. The DOD has stated that site-specific information will be released “in the future.” Government records are generally retained under federal schedules, but political and regulatory shifts may affect what is ultimately released. The risk is not destruction but delay and opacity — the DOD controls the timeline, and communities cannot afford to wait. Preservation demands should be sent to the appropriate military installation’s environmental office and to the DOD’s environmental programs office.
Blood serum PFAS testing for exposed individuals. This is the biological evidence of your internal dose. PFAS biological half-lives vary by compound — some are measured in years — but testing should occur before levels decline further from the exposure period. The clock on this evidence is your own biology. Every year that passes after exposure ends, your serum levels decline. If you were exposed decades ago, the window for capturing an accurate picture of your historical dose is narrowing. This is not a record that someone else holds — it is a test you need to take. The urgency is real.
Historical AFFF usage and training records at specific installations. These records establish where, when, how often, and in what quantities AFFF was used at your installation. They create the exposure timeline for your claim. DOD records management schedules may permit destruction of older records. Personnel turnover at military installations compounds the risk — institutional knowledge walks out the door when commands change. These records must be demanded through formal records requests and, once litigation is filed, through discovery. The preservation letter that goes out the day you call a lawyer should name these records specifically.
Environmental sampling data — drinking water wells, groundwater, soil. This data demonstrates contaminant migration patterns and concentration levels linking base contamination to off-base exposure pathways. Wright-Patterson’s data shows three of twenty-two private wells exceeding MCLs. Joint Base Cape Cod’s data shows active spreading toward Falmouth and Mashpee. Environmental data is typically retained by state and federal agencies, but sampling methodology and chain-of-custody documentation must be secured. If the sampling was done by a contractor, the contractor’s records may have a shorter retention period than the agency’s.
Internal manufacturer corporate documents on PFAS health knowledge. These documents establish what the manufacturers knew about health risks and when they knew it — the spine of the failure-to-warn theory and the engine of punitive damages. Much has been produced in the MDL discovery process, and that production is preserved through litigation holds. But additional documents may exist — and corporate restructuring creates long-term risk. Chemours was spun off from DuPont in 2015. Corporate retention policies, records transfers, and entity dissolution can all affect what survives. The MDL has done significant work here, but individual cases should not assume every relevant document has been produced.
Hydrogeological and contaminant transport modeling data. This data shows the direction and rate of groundwater contaminant migration from source areas to private wells and municipal water supplies. Harvard’s research at Joint Base Cape Cod demonstrates that precursors continue converting to PFAS over time, meaning the contamination burden is dynamic, not static. Site-specific modeling may be updated or superseded as new data arrives. The current model is evidence of what was known at the time it was prepared — it should be preserved as a snapshot, not assumed to remain permanently accessible in its current form.
Medical records documenting cancer diagnosis and treatment. These establish the injury element and the damages baseline. The temporal relationship between your exposure period and your diagnosis is critical for specific causation. Medical records must be obtained and preserved before provider retention periods expire — particularly for older diagnoses. Hospital and clinic retention periods vary by state and provider policy. Do not assume your medical records will be there in ten years. Request them now.
What the Defense Will Try: The Corporate Playbook and How to Counter It
The manufacturers and their insurers have a playbook. It is not unique to AFFF cases — it is the same set of moves used in every mass tort where a product caused latent disease. Knowing the plays before they run is the single biggest advantage you can give yourself.
Play 1: “PFAS is everywhere — you can’t prove our product caused your cancer.” This is the ubiquity defense. Because nearly everyone has some PFAS in their blood, the manufacturers argue you cannot single them out. The counter is dose and source. Blood serum testing that shows your PFAS levels at multiples of the national average, combined with documented residence near a contaminated installation or occupational exposure as a firefighter, distinguishes your exposure from background. The C8 Science Panel’s dose-response findings show that risk increases with dose. Your elevated levels are the answer to “everyone has it.”
Play 2: “Your cancer has other causes.” Kidney cancer has risk factors — smoking, obesity, hypertension, certain genetic conditions. Testicular cancer has its own risk profile. The defense will argue your disease was caused by something other than PFAS. The counter is the weight of the evidence. IARC’s Group 1 classification of PFOA, the C8 Science Panel’s probable-link findings, your documented exposure, your elevated blood serum levels, and the absence of equally strong alternative explanations combine to meet the “substantial contributing factor” standard that most states apply.
Play 3: “You waited too long — the statute of limitations has run.” The defense will argue that you knew or should have known about your exposure and your injury years ago, and that the filing deadline has passed. The counter is the discovery rule. For latent diseases, the clock starts when you discovered or should have discovered the connection between your injury and the toxic exposure — not when you were exposed. If you were diagnosed with cancer and only recently learned that the water near your home was contaminated with PFAS from AFFF at the military base, your clock may have started recently. But this is a state-by-state question, and some states have statutes of repose that can cut off claims regardless of discovery. Do not assume you are out of time — and do not assume you have plenty of time. Confirm the deadline for your state with a lawyer.
Play 4: The quick settlement offer. In some cases, the defense will offer a settlement before you have completed your medical evaluation, before your blood serum results are in, and before you understand the full scope of your future medical needs. A quick check arrives with a release that, once signed, extinguishes every claim you have — including claims for diseases you have not yet been diagnosed with. The counter is simple: do not sign anything until you have consulted a lawyer who handles toxic exposure cases. A settlement that looks adequate today may be a fraction of what your case is worth once the full medical picture is known.
Play 5: The recorded statement. A friendly investigator or claims representative may call to “check on you” and ask you to describe your exposure history, your medical history, and your current condition — on a recording. Everything you say will be transcribed and used to narrow your claim. The counter is the same as for any injury case: decline to give a recorded statement without legal representation. You are not required to help the defense build its file against you.
What Your Case Is Worth: Honest Valuation
Individual case values in the AFFF PFAS mass tort vary dramatically based on disease severity, exposure documentation, PFAS blood serum levels, jurisdiction, and defendant allocation. We will give you the honest range from our analysis, not a promise.
Medical monitoring claims — for individuals with documented elevated exposure but no current disease diagnosis — typically fall at the lower end of the range. These claims seek recovery of the costs of ongoing medical surveillance. The value is in the right to monitoring, not in a large lump sum. A rough floor for medical monitoring claims is approximately $250,000, though this varies by jurisdiction and the scope of monitoring recommended.
Cancer diagnosis claims — where an individual has been diagnosed with kidney cancer, testicular cancer, or another PFAS-linked condition and has well-documented exposure pathways near a contaminated military installation with confirmed elevated blood PFAS levels — can reach into the multiple millions. The upper end of the range, particularly in plaintiff-friendly jurisdictions with no punitive damage caps, can exceed $5,000,000 per individual claimant. Factors that drive value toward the higher end include: strong exposure documentation (long-term residence near a contaminated installation or significant occupational AFFF exposure as a firefighter), blood serum levels well above national background, a cancer diagnosis with a strong scientific link to PFAS (kidney and testicular cancer have the strongest links), younger age at diagnosis (more future medical costs and lost earning capacity), and jurisdiction in a state with favorable tort law and no punitive damage caps.
Wrongful death claims — where a family member has died from a PFAS-linked disease — may carry additional value through survival actions and wrongful death damages, including loss of financial support, loss of companionship, and the decedent’s pain and suffering before death. The survival-versus-wrongful-death damage split is governed by each claimant’s state law.
Property damage claims — where soil or groundwater contamination is documented on or near a claimant’s property — provide a separate stream of damages for diminution in property value, loss of use, and remediation costs.
Punitive damages — designed to punish the manufacturer for conduct that was willful, wanton, or reckless — may be available against manufacturers who allegedly possessed knowledge of PFAS health risks for decades but continued production and marketing. Punitive damages are subject to state-specific caps and constitutional limitations. The internal corporate documents produced in the MDL — showing what the manufacturers knew and when — are the evidence that supports a punitive damages argument.
Aggregate exposure across all manufacturer defendants is in the billions. The 3M public water settlement alone was approximately $10.3 billion in present value. But that is a water-provider settlement, not a personal-injury settlement. The personal-injury cases are still being litigated, and final valuations will depend on MDL bellwether trial outcomes, individual causation strength, and applicable state law.
We tell you all of this not to promise you a number but to give you the framework. The adjuster’s first offer will be a fraction of what your case is worth. Knowing the framework is how you recognize the difference.
How a Case Like This Is Actually Built
Here is how an AFFF PFAS case is built, from the day you call to the day a number is on the table.
Week one. The preservation letter goes out. It names every category of evidence — the DOD environmental records for your installation, the historical AFFF usage logs, the environmental sampling data, the manufacturer’s internal documents, your medical records. The letter puts every potential defendant and custodian on notice that evidence must be preserved. This is not a formality. It is the legal step that converts routine record destruction into spoliation — the destruction of evidence after notice that it is relevant to litigation.
Weeks one through four. We build your exposure profile. Where did you live? When? How far from the base? Did you drink from a private well or a municipal system? If you were a firefighter, how often did you train with AFFF? What years? What concentrations? We map your residential and occupational history against the known contamination timeline for your installation. We order your blood serum PFAS test. We obtain your complete medical records — not just the diagnosis, but the full treatment history, the pathology reports, the imaging, the lab trends that may show early hematological changes years before the cancer was diagnosed.
Months one through three. We retain the experts your case needs. An environmental toxicologist for general causation — linking PFAS to your disease in the scientific literature. An epidemiologist for dose-response — showing that your exposure level is associated with elevated risk. A hydrogeologist for contaminant transport modeling — tracing the PFAS from the fire training area on base to the water you drank. A treating oncologist or specialist for specific causation and damages — connecting your disease to the exposure and documenting your medical needs.
Months three through twelve. If your case is in the MDL, we leverage the centralized discovery — the corporate documents, the internal memos, the testing data that the manufacturers were forced to produce. If your case is an individual action, we conduct site-specific discovery on exposure pathways at your installation. We take depositions — of the manufacturer’s corporate representatives, of the base environmental officers, of the defense’s experts. Under oath, the safety director explains the company’s choices. The corporate representative explains what they knew about PFAS health risks and when they knew it.
The number. At the end of this process, a real number is built. It is not pulled from the air. It is built from the life-care planner’s cost stream — every surgery, every treatment, every year of medical care projected across your life expectancy. It is built from the forensic economist’s present-value calculation — reducing that future cost stream to today’s dollars. It is built from the lost-earning-capacity analysis — the wages you will never earn because of your disease. And it is built from the human losses — the pain, the fear, the life you no longer get to live. That is the number we put in the demand letter. And that is the number the adjuster’s first offer will be a fraction of.
Your First 72 Hours: What to Do Now
Get medical care first. If you have been diagnosed with cancer, your treatment is the priority. Follow your oncologist’s treatment plan. If you have not been diagnosed but have documented exposure to PFAS-contaminated water or occupational AFFF exposure, talk to your doctor about a blood serum PFAS test and an appropriate cancer screening schedule. Your health comes before your case.
Get the blood test. A blood serum PFAS test documents your internal dose. It is the biological evidence that connects your exposure to the contamination at the base. The test is not routine — you may need to request it specifically or have it ordered through a physician familiar with PFAS biomonitoring. The sooner you test, the more accurate the picture of your historical exposure.
Document your exposure history. Write down where you lived and when. Note the dates you lived near a military base, the name of the installation, whether you drank from a private well or municipal water, and how far your home was from the base. If you were a firefighter, document your AFFF training history — the years, the frequency, the type of foam, the base or facility. This timeline is the backbone of your exposure claim.
Do not sign anything. If you receive a settlement offer, a release, or a request for a recorded statement from any party — an insurance company, a claims administrator, a manufacturer’s representative — do not sign it and do not give the statement. These documents are designed to limit or eliminate your rights. Everything you sign and everything you say can and will be used to narrow your claim.
Do not post about your case on social media. The defense monitors social media. Posts about your health, your activities, your emotional state, and your legal intentions can be taken out of context and used against you. Assume everything you post is being read by someone whose job is to find reasons to pay you less.
Call a lawyer. The preservation letter that freezes the evidence goes out the day you call. The blood test guidance, the medical records request, the exposure profile mapping — all of it starts when you make the call. The consultation is free. We do not get paid unless we win your case.
Why Attorney911
Ralph Manginello has spent 27-plus years in courtrooms, including federal court. He was a journalist before he was a lawyer, which means he learned early that the strongest case is the one built on facts you can prove, not arguments you can invent. He built this firm to take the cases where the company on the other side is bigger than the person on this side — and to win them anyway.
Lupe Peña spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like you. He knows how claims are valued from the inside, how reserves are set in the first 48 hours, how recorded statements are engineered, and how the quick settlement check is designed to arrive before the medical results do. He now sits on your side of the table. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter.
We handle toxic tort claims and the wrongful death cases that follow them. We work on contingency — 33.33% before trial, 40% if the case goes to trial. You pay nothing unless we recover for you. The consultation is free. Our staff is live 24 hours a day, 7 days a week — not an answering service.
Past results depend on the facts of each case and do not guarantee future outcomes. What we can promise is that the analysis you receive will be honest, the evidence will be pursued aggressively, and the decision about whether to pursue your case will be based on what is best for you — not what is easiest for us. If we are not the right fit for your case, we will tell you.
Frequently Asked Questions
Can I sue for PFAS exposure from a military base?
Yes. If you lived, worked, or served at or near a military installation where AFFF was used and you have been diagnosed with a PFAS-linked health condition — kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, or pregnancy-induced hypertension — you may have a claim against the AFFF chemical manufacturers. Claims against the DOD itself face additional barriers under the Federal Tort Claims Act but are possible in some circumstances. The strength of your claim depends on your exposure documentation, your blood serum PFAS levels, your diagnosis, and the applicable state law. The only way to know for certain is to consult a lawyer who handles toxic exposure cases.
What cancers are linked to AFFF firefighting foam?
The C8 Science Panel found a “probable link” between PFOA and kidney cancer and testicular cancer. The International Agency for Research on Cancer classified PFOA as Group 1 — carcinogenic to humans — and PFOS as Group 2B — possibly carcinogenic. PFAS exposure has also been linked to thyroid disease, high cholesterol, ulcerative colitis, and pregnancy-induced hypertension. The scientific evidence connecting PFAS to kidney cancer and testicular cancer is the strongest and most extensively studied.
How long do I have to file an AFFF PFAS lawsuit?
The deadline depends on your state’s statute of limitations and whether the discovery rule applies. For latent diseases like cancer that may not appear until decades after exposure, most states apply a discovery rule — the clock starts when you discovered or should have discovered the connection between your injury and the toxic exposure, not when you were exposed. Toxic tort statutes of limitation typically run two to three years from the date of discovery. Some states have statutes of repose that can cut off claims regardless of discovery. For claims against the federal government under the FTCA, you have two years to file an administrative claim and six months to sue after denial. Confirm the specific deadline for your state with a lawyer — do not assume you are out of time, and do not assume you have plenty of time.
What is the AFFF MDL in South Carolina?
The AFFF multidistrict litigation — MDL number 2873, In re: Aqueous Film-Forming Foams Products Liability Litigation — is consolidated in the U.S. District Court for the District of South Carolina before Judge Richard M. Gergel. As of mid-2026, approximately 15,240 actions were pending. The MDL centralizes pretrial proceedings — discovery, motion practice, expert challenges — so that shared evidence and legal questions are handled once rather than in thousands of individual cases. Each plaintiff keeps an individual case. The MDL is not a class action, and its bellwether trial results do not bind other plaintiffs.
How do I know if I was exposed to PFAS?
If you lived near a military base where AFFF was used for firefighter training or jet fuel fire suppression, you may have been exposed through contaminated drinking water. If you served as a military or civilian firefighter and trained with AFFF, you were exposed occupationally. The DOD has identified more than 700 installations with confirmed or likely PFAS contamination. You can check whether your installation is on that list through the DOD’s PFAS progress report. The only way to confirm your personal exposure level is a blood serum PFAS test, which measures the concentration of PFAS compounds in your blood.
What is blood testing for PFAS?
A blood serum PFAS test is a clinical biomonitoring test that measures the concentration of specific PFAS compounds — typically PFOA, PFOS, PFHxS, PFNA, and others — in your blood serum. Results are reported in nanograms per milliliter and compared against national background levels from the CDC’s National Health and Nutrition Examination Survey. The test documents your internal dose — the actual amount of PFAS in your body. It is not a routine blood test and may need to be specifically requested or ordered through a physician familiar with PFAS biomonitoring. Testing sooner rather than later is important because PFAS levels gradually decline after exposure stops.
Is the DOD cleaning up the PFAS contamination?
The DOD is required by Congress to phase out PFAS in AFFF by October 1, 2026, and some bases — like Wright-Patterson Air Force Base in Ohio — have already completed the transition to fluorine-free foam. But the F3 transition only stops new contamination. It does nothing about the decades of PFAS already in the soil and groundwater. A mid-2026 investigation found that the DOD has delayed PFAS cleanup timelines at 178 sites, pushing remediation back between one and twenty years. Harvard research indicates that without remediation, elevated PFAS exposure near more than 300 military facilities could persist for centuries. The cleanup is not keeping pace with the contamination.
What is my AFFF PFAS case worth?
Case values vary based on disease severity, exposure documentation, PFAS blood serum levels, jurisdiction, and defendant allocation. Medical monitoring claims for exposed-but-asymptomatic individuals typically fall at the lower end — approximately $250,000. Cancer diagnosis claims with well-documented exposure and elevated blood PFAS levels can reach into the multiple millions — potentially $5,000,000 or more per individual claimant in plaintiff-friendly jurisdictions. Wrongful death claims and property damage claims provide additional streams of recovery. Punitive damages may be available against manufacturers who possessed knowledge of PFAS health risks for decades. These are framework figures, not promises. The only way to value your specific case is through a consultation with a lawyer who can evaluate your exposure history, your medical records, and your jurisdiction’s law.
If I was a firefighter who used AFFF, is my case different from a community resident’s case?
Yes. Military and civilian firefighters who handled AFFF directly typically have far higher PFAS blood serum levels than community members exposed through drinking water. Occupational exposure to AFFF concentrate produces some of the highest PFAS blood levels ever recorded in humans. This means your dose is higher, your causation evidence is stronger, and your case may carry higher value. But it also means your exposure documentation is different — you need records of your AFFF training history, the years and frequency of use, the type of foam, and the base or facility where you trained. If you were a firefighter, tell your lawyer that specifically — it changes the exposure profile and the strategy.
Can I join the AFFF lawsuit if I do not have cancer but I was exposed?
Yes. Medical monitoring is a recognized claim for individuals with documented elevated PFAS exposure but no current disease diagnosis. If you lived near a contaminated installation and have elevated blood serum PFAS levels, you may be entitled to recover the costs of ongoing medical surveillance — regular blood tests, cancer screenings, thyroid panels — designed to detect disease at earlier and more treatable stages. The Harvard research showing that PFAS precursors in soil can continue generating contamination for centuries means that your exposure may be ongoing, and medical monitoring is how the law addresses the reality of living with elevated risk.
You Do Not Have to Do This Alone
If you or someone you love has been diagnosed with cancer after living near a military base where AFFF was used — or if you served as a firefighter and held the foam in your own hands — the science connecting your disease to that exposure is real, the manufacturers knew about the risk for decades, and the law gives you a path to hold them accountable.
The call is free. The consultation is free. We do not get paid unless we win your case. The preservation letter that freezes the evidence before it disappears goes out the day you call. The blood test guidance, the medical records request, the exposure profile mapping — all of it starts with one phone call.
Call 1-888-ATTY-911. That is 1-888-288-9911. Our staff is live, 24 hours a day, 7 days a week. Contact us through our website at any hour. Hablamos Español — we serve your family fully in Spanish.
The chemical companies had decades to warn you. They chose not to. You have the right to ask why — and to make them answer for it.